Fundz

Integrated Biotherapeutics reported raising $1 Million in an initial SEC Form D filing, from an offering of $1 Million

PRIVATEMay 10, 2023

Amount Raised

$1 Million

$1 Million sold, per SEC Form D (first sale May 1, 2023)

Round Type

Seed

RockvilleBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Integrated Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Beekeeper's Naturals raised $14M (Funding Round) on June 15, 2023.
  • Neuvivo raised $11M (Funding Round) on June 15, 2023.
  • Metagen Therapeutics raised an undisclosed amount (Series A) on June 15, 2023.
  • Theradaptive raised $26M (Series A) on June 15, 2023.
  • Zucara Therapeutics raised an undisclosed amount (Funding Round) on June 15, 2023.
  • Beyond Air raised $40M (Debt Financing) on June 15, 2023.

Who to call at Integrated Biotherapeutics, and when

A new round usually means Integrated Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Integrated Biotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Integrated Biotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Integrated Biotherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Integrated Biotherapeutics

Location

4 RESEARCH CT

Rockville, Maryland, United States

About

Integrated BioTherapeutics Inc (IBT) is the 2009 Emerging Company of the Year in Maryland. IBT is a research-based company dedicated to development of vaccines and biotherapeutic molecules targeting emerging infectious agents. We are located in Gaithersburg, Maryland. Our primary areas of focus is on Ebola and Marburg viral hemorrhagic fevers and staph aureus. IBT is developing a panfilovirus vaccine under a contract with NIAID. In addition IBT is also testing an SEB vaccine in phase I trials sponsored by NIH. IBT has a close working arrangement with many of the United States government agencies including the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), National Cancer Institute (NCI), National Institute of Health (NIH), and the Department of Defense (DOD). IBT Bioservices is our contract R&D services business. IBT Bioservices is developing screening assays and disease models to identify antiviral and antibacterial compounds and therapeutics for client companies. In addition, we offer contract testing using the Mesoscale Discovery platform by MSD. You can learn more about IBT Bioservices at www.ibtbioservices.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Integrated Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJavad A., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Integrated Biotherapeutics's next move

See what Strategic adds

Integrated Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.